...
首页> 外文期刊>Journal of Clinical Oncology >The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas.
【24h】

The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas.

机译:磷脂酰肌醇3-激酶途径激活在人脑胶质瘤中的预后意义。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: The objectives of this study were to examine activation patterns of the phosphatidylinositol 3-kinase (PI3K) pathway in gliomas and to examine the prognostic significance of PI3K pathway activation using snap-frozen clinical specimens. MATERIALS AND METHODS: Levels of expression of PI3K pathway members were assessed in 92 prospectively collected gliomas through quantitative Western analysis using total and phospho-specific antibodies for PI3K, Akt, and p70(s6k). Both expression and expression levels of these PI3K pathway members were correlated with histology, markers of apoptosis (cleaved caspase 3), and with clinical outcome (eg, overall survival). RESULTS: It was determined that activation of all three PI3K pathway members were significantly more frequent in glioblastoma multiforme than in non-glioblastoma multiforme tumors. Levels of phospho-PI3K, phospho-Akt, and phospho-p70(s6k) were all found to be inversely associated with cleaved caspase 3 levels, suggesting PI3K pathway activation isassociated with reduced levels of apoptosis. Perhaps most importantly, activation of PI3K pathway members was found to be significantly associated with reduced survival times when all glioma cases were considered in aggregate. When glioblastoma cases were considered separately, the prognostic value of PI3K activation remained significant, suggesting that PI3K activation may directly be associated with radiation resistance, given that this was the only adjuvant therapy administered to this subset of patients. CONCLUSION: Activation of the PI3K pathway is significantly associated with increasing tumor grade, decreased levels of apoptosis, and with adverse clinical outcome in human gliomas. Molecular pathways regulating PI3K activation would appear to be promising targets in the clinical management of glioma patients.
机译:目的:本研究的目的是检查神经胶质瘤中磷脂酰肌醇3-激酶(PI3K)途径的激活模式,并使用速冻临床标本检查PI3K途径激活的预后意义。材料与方法:通过定量的Western分析,采用针对PI3K,Akt和p70(s6k)的总抗体和磷酸特异性抗体,通过定量Western分析评估了PI3K途径成员的表达水平。这些PI3K途径成员的表达和表达水平均与组织学,细胞凋亡的标志物(裂解的半胱天冬酶3)以及临床结果(例如总生存期)相关。结果:确定多形性胶质母细胞瘤中所有三个PI3K途径成员的激活均显着高于非多形性胶质母细胞瘤。磷酸-PI3K,磷酸-Akt和磷酸-p70(s6k)的水平都被发现与裂解的胱天蛋白酶3水平成反比,表明PI3K途径激活与减少的细胞凋亡水平相关。也许最重要的是,当将所有神经胶质瘤病例综合考虑时,发现PI3K途径成员的激活与生存时间的缩短显着相关。当单独考虑成胶质细胞瘤病例时,PI3K激活的预后价值仍然很显着,这表明PI3K激活可能直接与放射线抗性相关,因为这是对这部分患​​者进行的唯一辅助治疗。结论:PI3K通路的激活与人脑胶质瘤的肿瘤分级升高,细胞凋亡水平降低以及不良的临床预后密切相关。调节PI3K激活的分子途径似乎是神经胶质瘤患者临床管理中有希望的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号